JAMA Pediatr:全球儿童高血压发病率研究

2019-10-08 MedSci MedSci原创

研究首次对儿童高血压的患病率进行了系统研究,为高血压的预防和治疗提供了根据

近日研究人员对普通儿科人群高血压患病率进行系统评价和荟萃分析。

收集截至2018年6月的相关研究,研究的主要终点为儿童高血压患病率以及各亚组患病率。

47个研究纳入本次荟萃研究。19岁及以下儿童中,高血压综合患病率为4.00%,高血压前期患病率为9.67%,高血压1期患病率为4.00%,高血压2期患病率为0.95%。在亚组分析中,采用合式血压表测量时,儿童高血压的患病率较高(7.23% vs 水银血压计4.59% vs 振荡血压计2.94%),超重和肥胖儿童(15.27% vs 4.99% vs 正常体重儿童1.90%)的高血压比例较高。在过去20年中,儿童高血压患病率呈上升趋势,2000年至2015年相对上升75%-79%,2015年,6岁儿童高血压患病率从4.32%到19岁儿童的3.28%,峰值为7.89%。

研究首次对儿童高血压的患病率进行了系统研究,为高血压的预防和治疗提供了根据。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2018318, encodeId=5d042018318ac, content=<a href='/topic/show?id=4bfa2853506' target=_blank style='color:#2F92EE;'>#儿童高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28535, encryptionId=4bfa2853506, topicName=儿童高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Wed Aug 26 00:20:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728157, encodeId=1dd01e281576c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Mar 07 22:20:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639235, encodeId=176c16392353d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Jul 12 21:20:00 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823584, encodeId=6787182358493, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Dec 21 08:20:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374381, encodeId=a0743e438198, content=牛逼, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 10:20:15 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2018318, encodeId=5d042018318ac, content=<a href='/topic/show?id=4bfa2853506' target=_blank style='color:#2F92EE;'>#儿童高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28535, encryptionId=4bfa2853506, topicName=儿童高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Wed Aug 26 00:20:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728157, encodeId=1dd01e281576c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Mar 07 22:20:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639235, encodeId=176c16392353d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Jul 12 21:20:00 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823584, encodeId=6787182358493, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Dec 21 08:20:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374381, encodeId=a0743e438198, content=牛逼, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 10:20:15 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2020-03-07 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=2018318, encodeId=5d042018318ac, content=<a href='/topic/show?id=4bfa2853506' target=_blank style='color:#2F92EE;'>#儿童高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28535, encryptionId=4bfa2853506, topicName=儿童高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Wed Aug 26 00:20:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728157, encodeId=1dd01e281576c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Mar 07 22:20:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639235, encodeId=176c16392353d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Jul 12 21:20:00 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823584, encodeId=6787182358493, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Dec 21 08:20:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374381, encodeId=a0743e438198, content=牛逼, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 10:20:15 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2018318, encodeId=5d042018318ac, content=<a href='/topic/show?id=4bfa2853506' target=_blank style='color:#2F92EE;'>#儿童高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28535, encryptionId=4bfa2853506, topicName=儿童高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Wed Aug 26 00:20:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728157, encodeId=1dd01e281576c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Mar 07 22:20:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639235, encodeId=176c16392353d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Jul 12 21:20:00 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823584, encodeId=6787182358493, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Dec 21 08:20:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374381, encodeId=a0743e438198, content=牛逼, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 10:20:15 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2019-12-21 lifestar
  5. [GetPortalCommentsPageByObjectIdResponse(id=2018318, encodeId=5d042018318ac, content=<a href='/topic/show?id=4bfa2853506' target=_blank style='color:#2F92EE;'>#儿童高血压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28535, encryptionId=4bfa2853506, topicName=儿童高血压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Wed Aug 26 00:20:00 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728157, encodeId=1dd01e281576c, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Mar 07 22:20:00 CST 2020, time=2020-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639235, encodeId=176c16392353d, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Jul 12 21:20:00 CST 2020, time=2020-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1823584, encodeId=6787182358493, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Dec 21 08:20:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374381, encodeId=a0743e438198, content=牛逼, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 10:20:15 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    牛逼

    0

相关资讯

JACC:无创立体定向放射治疗高血压安全有效

近期的临床随机对照研究显示基于导管的去肾神经术(RDN)在治疗高血压方面有良好的效果,本研究的目的旨在评估无创立体定向放射治疗(SBRT)作为RDN的一种的可行性、安全性和有效性。本研究对12只血压正常的小型猪的24条肾动脉进行了SBRT治疗,剂量分别为25、35和45Gy(每组n=4),另外4只小型猪作为对照。并对实验动物的基线、治疗后7天、1个月和3个月的血压、肾功能和血清去甲肾上腺素(NE)

Hypertension:诊室外血压对高血压及相关心血管病更具预测价值

高血压及高血压性心脏病的发病率具有显著种族差异。近期发表于Hypertension杂志的一项研究以发病率较高的美国人群为基础展开,评估诊室外血压与临床血压对高血压性心脏病的预测能力。

Blood:依鲁替尼可诱导高血压和其他心血管事件的发生发展

依鲁替尼对B细胞恶性肿瘤有显著疗效。依鲁替尼与潜在的限制性心脏毒性有关,包括高血压。但在依鲁替尼治疗期间,高血压的长期发病率、严重程度及影响尚不明确。现研究人员对2009-2016年期间的562位采用依鲁替尼治疗的B细胞恶性肿瘤患者的高血压发病情况进行评估。将观察到的高血压发生率与Framingham-心脏预测的高血压发生率相比较。同时,还评估了依鲁替尼诱导性高血压与其他主要心血管事件(MACE,

J Clin Hypertens:随机双盲研究称:高血压伴糖尿病患者,初始应选择以培哚普利为基础的联合降压

2型糖尿病和高血压均是心血管和肾脏并发症的危险因素。两者往往会同时存在,2型糖尿病患者中高血压比普通人群更常见,估计超过50%。

J Clin Hypertens:世界高血压联盟请求各国政府:在食盐包装上添加警示“吃盐过多有害健康!”

9月25日,世界高血压联盟联合多个国家、国际健康和科学组织发表立场声明,请求各国政府在市场售卖的食盐包装以及盐调味瓶上印上健康警示标签。

Blood:依鲁替尼治疗后的高血压和心血管事件

总的来说,这些数据表明依鲁替尼与高血压的发病率和严重程度的显著增加有关,并且高血压的发生发展可能提示随后发生心脏毒性事件的风险更高。